Global Skin Grafting Device Market 規模およびシェア分析 - 成長トレンドおよび予測 (2023 - 2030)

Global Skin Grafting Device Market is Segmented By Product Type (Dermal Substitutes, Acellular, Cellular Allogeneic, Cellular Autologous, Others), By Graft Thickness (Split-Thickness, Full-Thickness, Composite Grafts), By Application (Burns, Traumatic Wounds, Surgical Wounds, Chronic Wounds, Others), By End user (Hospitals, Clinics, Ambulatory Surgical Centers, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned segments.

Competitive overview of Global Skin Grafting Device Market

Avita Medical、Smith & Nephew、MiMedx Group、Organogenesis、Zimmer Biomet、Medtronic、Tissue Regenix、Integra Lifescience、Anika Therapeutics、Nouvag、AlloSource、Merakris Therapeutics、LLC

Global Skin Grafting Device Market Leaders

  • Avita メディカル
  • スミス&ネフ
  • ミメデックスグループ
  • オルガンジェネシス
  • ジマーバイオメット
*Disclaimer: Major players are listed in no particular order.

Global Skin Grafting Device Market - Competitive Rivalry, 2023

Market Concentration Graph

Global Skin Grafting Device Market

Market Consolidated
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
*Source: Coherent Market Insights